Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

PHASE3TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 21, 2005

Primary Completion Date

September 11, 2007

Study Completion Date

September 11, 2007

Conditions
Infection, Human Immunodeficiency Virus I
Interventions
DRUG

GW873140

400 mg twice daily

Trial Locations (55)

10014

GSK Investigational Site, New York

10550

GSK Investigational Site, Mount Vernon

20009

GSK Investigational Site, Washington D.C.

20037

GSK Investigational Site, Washington D.C.

21201

GSK Investigational Site, Baltimore

22003

GSK Investigational Site, Annandale

23666

GSK Investigational Site, Hampton

24501

GSK Investigational Site, Lynchburg

28209

GSK Investigational Site, Charlotte

30033

GSK Investigational Site, Decatur

30339

GSK Investigational Site, Atlanta

32804

GSK Investigational Site, Orlando

33040

GSK Investigational Site, Key West

33136

GSK Investigational Site, Miami

33306

GSK Investigational Site, Fort Lauderdale

33308

GSK Investigational Site, Fort Lauderdale

33317

GSK Investigational Site, Plantation

33334

GSK Investigational Site, Oakland Park

33901

GSK Investigational Site, Fort Myers

35294

GSK Investigational Site, Birmingham

44304

GSK Investigational Site, Akron

55404

GSK Investigational Site, Minneapolis

60613

GSK Investigational Site, Chicago

60657

GSK Investigational Site, Chicago

63108

GSK Investigational Site, St Louis

67214

GSK Investigational Site, Wichita

75246

GSK Investigational Site, Dallas

77027

GSK Investigational Site, Houston

78746

GSK Investigational Site, Austin

89102

GSK Investigational Site, Las Vegas

90046

GSK Investigational Site, Los Angeles

90069

GSK Investigational Site, Los Angeles

90210

GSK Investigational Site, Beverly Hills

90813

GSK Investigational Site, Long Beach

91356

GSK Investigational Site, Tarzana

92651

GSK Investigational Site, Laguna Beach

92708

GSK Investigational Site, Fountain Valley

94114

GSK Investigational Site, San Francisco

94609

GSK Investigational Site, Oakland

97209

GSK Investigational Site, Portland

97219

GSK Investigational Site, Portland

99204

GSK Investigational Site, Spokane

06033

GSK Investigational Site, Glastonbury

06851

GSK Investigational Site, Norwalk

30308/30309

GSK Investigational Site, Atlanta

70127-0800

GSK Investigational Site, New Orleans

04102

GSK Investigational Site, Portland

02215

GSK Investigational Site, Boston

07018

GSK Investigational Site, East Orange

08844

GSK Investigational Site, Hillsborough

07102

GSK Investigational Site, Newark

29206-4713

GSK Investigational Site, Columbia

M5B 1L6

GSK Investigational Site, Toronto

00731

GSK Investigational Site, Ponce

00910

GSK Investigational Site, San Juan

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY